EDGAR Filing Documents for 0001123292-17-000242

Form 3 - Initial statement of beneficial ownership of securities:

SEC Accession No. 0001123292-17-000242

Filing Date

2017-01-25

Accepted

2017-01-25 11:04:17

Documents

Period of Report

2017-01-18

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	edgar.html	3
1	PRIMARY DOCUMENT	edgar.xml	3	1574
	Complete submission text file	0001123292-17-000242.txt		3094

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333

Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505

Zynerba Pharmaceuticals, Inc. (Issuer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZYNERBA PHARMACEUTICALS, INC. 80 WEST LANCASTER AVENUE, SUITE 300 DEVON PA 19333

Business Address

Type: 3 | Act: 34 | File No.: 001-37526 | Film No.: 17545341